Enfermedad de Chagas


Artículos principales

Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018 Sep 18;138(12):e169-209.Texto completo  Resumen

Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin North Am. 2012 Jun;26(2):275-91. Resumen

Brazilian Ministry of Health. Brazilian consensus on Chagas disease [in Portuguese]. Rev Soc Bras Med Trop. 2005;38(suppl 3):7-29. Resumen

Andrade JP, Marin Neto JA, Paola AA, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011 Jun;96(6):434-42.Texto completo  Resumen

Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007 Nov 14;298(18):2171-81.Texto completo  Resumen

Meymandi S, Hernandez S, Park S, et al. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018 Jun 26;10(3):373-88.Texto completo  Resumen

Artículos de referencia

1. Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018 Jan 6;391(10115):82-94.Texto completo  Resumen

2. Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018 Sep 18;138(12):e169-209.Texto completo  Resumen

3. Siqueira Batista R, Gomes AP, Corrêa AD, et al. Moléstia de Chagas. 2nd ed. Rio de Janeiro: Rubio;2007:248.

4. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010 Apr 17;375(9723):1388-402. Resumen

5. Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin North Am. 2012 Jun;26(2):275-91. Resumen

6. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007 Jan;101(1):31-50. Resumen

7. Cordova E, Maiolo E, Corti M, et al. Neurological manifestations of Chagas' disease. Neurol Res. 2010 Apr;32(3):238-44. Resumen

8. Almeida EA, Lima JN, Lages-Silva E, et al. Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg. 2010 Jul;104(7):447-52. Resumen

9. Almeida EA, Ramos AN Jr, Correia D, et al. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010). Rev Soc Bras Med Trop. 2011 Nov-Dec;44(6):762-70.Texto completo  Resumen

10. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis. 2012 Mar;54(6):845-52.Texto completo  Resumen

11. Pereira KS, Schmidt FL, Barbosa RL, et al. Transmission of Chagas disease (American trypanosomiasis) by food. Adv Food Nutr Res. 2010;59:63-85. Resumen

12. Bennett C, Straily A, Haselow D, et al. Chagas disease surveillance activities - seven states, 2017. MMWR Morb Mortal Wkly Rep. 2018 Jul 6;67(26):738-41.Texto completo  Resumen

13. Coura JR, Dias JC. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40.Texto completo  Resumen

14. Brazilian Ministry of Health. Brazilian consensus on Chagas disease [in Portuguese]. Rev Soc Bras Med Trop. 2005;38(suppl 3):7-29. Resumen

15. Andrade JP, Marin Neto JA, Paola AA, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011 Jun;96(6):434-42.Texto completo  Resumen

16. Pinazo MJ, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011 Jul;25(3):91-101. Resumen

17. Sartori AM, Sotto MN, Braz LM, et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):631-2. Resumen

18. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients - a review. Mem Inst Oswaldo Cruz. 2002 Jun;97(4):443-57.Texto completo  Resumen

19. Ferreira MS. Chagas disease and immunosuppression. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:325-7.Texto completo  Resumen

20. Gray EB, La Hoz RM, Green JS, et al. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016. Transpl Infect Dis. 2018 Dec;20(6):e12996. Resumen

21. Ramos AN Jr. Inclusion of Chagas' disease reactivation as a condition for AIDS case definition to epidemiological surveillance in Brazil [in Portuguese]. Rev Soc Bras Med Trop. 2004 Mar-Apr;37(2):192-3.Texto completo  Resumen

22. Sartori AM, Neto JE, Nunes EV, et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis. 2002 Sep 15;186(6):872-5.Texto completo  Resumen

23. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:101-7.Texto completo  Resumen

24. Pereira KS, Schmidt FL, Guaraldo AM, et al. Chagas' disease as a foodborne illness. J Food Prot. 2009 Feb;72(2):441-6. Resumen

25. Nóbrega AA, Garcia MH, Tatto E, et al. Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil. Emerg Infect Dis. 2009 Apr;15(4):653-5.Texto completo  Resumen

26. Pinto AY, Ferreira AG Jr, Valente Vda C, et al. Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev Panam Salud Publica. 2009 Jan;25(1):77-83. Resumen

27. Pan American Health Organization. Guía para vigilancia, prevención, controle y manejo clínico da doença de Chagas aguda transmitida por alimentos [in Portuguese]. Rio de Janeiro, Brazil: PANAFTOSA-VP/OPAS/OMS: PAHO/HSD/CD/539.09; 2009:92.Texto completo

28. Alarcón de Noya B, Díaz-Bello Z, Colmenares C, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010 May 1;201(9):1308-15.Texto completo  Resumen

29. Dias JC, Coura JR. Clinica e terapeutica da doença de Chagas. Rio de Janeiro, Brazil: FIOCRUZ; 1997:486.

30. World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43.Texto completo  Resumen

31. TDR. Report of the scientific working group on Chagas disease, 17-20 April 2005 [in Spanish]. Buenos Aires, Argentina; 2007.Texto completo

32. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009;104(suppl 1):17-30.Texto completo  Resumen

33. Pinto Dias JC. Human Chagas disease and migration in the context of globalization: some particular aspects. J Trop Med. 2013;2013:789758.Texto completo  Resumen

34. Coura JR, Viñas PA, Junqueira AC. Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries. Mem Inst Oswaldo Cruz. 2014 Nov;109(7):856-62.Texto completo  Resumen

35. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007 Nov 14;298(18):2171-81.Texto completo  Resumen

36. Kirchhoff LV. American trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. N Engl J Med. 1993 Aug 26;329(9):639-44. Resumen

37. Strasen J, Williams T, Ertl G, et al. Epidemiology of Chagas disease in Europe: many calculations, little knowledge. Clin Res Cardiol. 2014 Jan;103(1):1-10. Resumen

38. Beard CB, Pye G, Steurer FJ, et al. Chagas disease in a domestic transmission cycle in southern Texas, USA. Emerg Infect Dis. 2003 Jan;9(1):103-5.Texto completo  Resumen

39. Kjos SA, Snowden KF, Craig TM, et al. Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol. 2008 Apr 15;152(3-4):249-56. Resumen

40. Yabsley MJ, Noblet GP. Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia. J Wildl Dis. 2002 Jan;38(1):75-83.Texto completo  Resumen

41. Klotz SA, Dorn PL, Klotz JH, et al. Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease. Acta Trop. 2009 Aug;111(2):114-8. Resumen

42. Hall CA, Polizzi C, Yabsley MJ, et al. Trypanosoma cruzi prevalence and epidemiologic trends in lemurs on St. Catherines Island, Georgia. J Parasitol. 2007 Feb;93(1):93-6. Resumen

43. Coura JR, Borges-Pereira J. Chagas disease. What is known and what should be improved: a systemic review. Rev Soc Bras Med Trop. 2012 Jun;45(3):286-96.Texto completo  Resumen

44. Buekens P, Almendares O, Carlier Y, et al. Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Matern Child Health J. 2008 May;12(3):283-6. Resumen

45. Coura JR. The main sceneries of Chagas disease transmission: the vectors, blood and oral transmissions - a comprehensive review. Mem Inst Oswaldo Cruz. 2015 May;110(3):277-82.Texto completo  Resumen

46. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001 Sep;1(2):92-100. Resumen

47. Roque AL, Xavier SC, da Rocha MG, et al. Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks. Am J Trop Med Hyg. 2008 Nov;79(5):742-9. Resumen

48. Roque AL, Xavier SC, Gerhardt M, et al. Trypanosoma cruzi among wild and domestic mammals in different areas of the Abaetetuba municipality (Pará State, Brazil), an endemic Chagas disease transmission area. Vet Parasitol. 2013 Mar 31;193(1-3):71-7.Texto completo  Resumen

49. Roux E, de Fátima Venâncio A, Girres JF, et al. Spatial patterns and eco-epidemiological systems--part II: characterising spatial patterns of the occurrence of the insect vectors of Chagas disease based on remote sensing and field data. Geospat Health. 2011 Nov;6(1):53-64. Resumen

50. Roux E, de Fátima Venâncio A, Girres JF, et al. Spatial patterns and eco-epidemiological systems--part I: multi-scale spatial modelling of the occurrence of Chagas disease insect vectors. Geospat Health. 2011 Nov;6(1):41-51. Resumen

51. Costa J, Lorenzo M. Biology, diversity and strategies for the monitoring and control of triatomines - Chagas disease vectors. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:46-51.Texto completo  Resumen

52. Justi SA, Russo CA, Mallet JR, et al. Molecular phylogeny of Triatomini (Hemiptera: Reduviidae: Triatominae). Parasit Vectors. 2014 Mar 31;7:149.Texto completo  Resumen

53. Justi SA, Galvão C. The Evolutionary Origin of Diversity in Chagas Disease Vectors. Trends Parasitol. 2017 Jan;33(1):42-52.Texto completo  Resumen

54. Herrera CP, Licon MH, Nation CS, et al. Genotype diversity of Trypanosoma cruzi in small rodents and Triatoma sanguisuga from a rural area in New Orleans, Louisiana. Parasit Vectors. 2015 Feb 24;8:123.Texto completo  Resumen

55. Waleckx E, Suarez J, Richards B, et al. Triatoma sanguisuga blood meals and potential for Chagas disease, Louisiana, USA. Emerg Infect Dis. 2014 Dec;20(12):2141-3.Texto completo  Resumen

56. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009 Sep 1;49(5):e52-4.Texto completo  Resumen

57. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev. 2001 Oct;14(4):659-88.Texto completo  Resumen

58. Messenger LA, Bern C. Congenital Chagas disease: current diagnostics, limitations and future perspectives. Curr Opin Infect Dis. 2018 Oct;31(5):415-21. Resumen

59. Luquetti AO, Tavares SBN, Siriano LR, et al. Congenital transmission of Trypanosoma cruzi in central Brazil: a study of 1,211 individuals born to infected mothers. Mem Inst Oswaldo Cruz. 2015 May;110(3):369-76.Texto completo  Resumen

60. Howard EJ, Xiong X, Carlier Y, et al. Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis. BJOG. 2014 Jan;121(1):22-33.Texto completo  Resumen

61. Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009 Dec 1;49(11):1667-74.Texto completo  Resumen

62. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:152-8.Texto completo  Resumen

63. Marin-Neto JA, Cunha-Neto E, Maciel BC, et al. Pathogenesis of chronic Chagas heart disease. Circulation. 2007 Mar 6;115(9):1109-23.Texto completo  Resumen

64. Esper L, Talvani A, Pimentel P, et al. Molecular mechanisms of myocarditis caused by Trypanosoma cruzi. Curr Opin Infect Dis. 2015 Jun;28(3):246-52. Resumen

65. Cunha-Neto E, Chevillard C. Chagas disease cardiomyopathy: immunopathology and genetics. Mediators Inflamm. 2014;2014:683230.Texto completo  Resumen

66. da Rocha JR, Ribeiro U, Cecconello I, et al. Gastric secretory and hormonal patterns in end-stage Chagasic achalasia. Dis Esophagus. 2009;22(7):606-10. Resumen

67. Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis. 2008 Jun;21(3):287-92. Resumen

68. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res. 1985;18(3):255-64. Resumen

69. Jabari S, de Oliveira EC, Brehmer A, et al. Chagasic megacolon: enteric neurons and related structures. Histochem Cell Biol. 2014 Sep;142(3):235-44.Texto completo  Resumen

70. Jiménez P, Jaimes J, Poveda C, et al. A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy. Parasitology. 2019 Mar;146(3):269-83. Resumen

71. Klotz SA, Dorn PL, Mosbacher M, et al. Kissing bugs in the United States: risk for vector-borne disease in humans. Environ Health Insights. 2014 Dec 10;8(Suppl 2):49-59.Texto completo  Resumen

72. Dias JC. Chagas disease control in Brazil: which strategy after the attack phase? Ann Soc Belg Med Trop. 1991;71(suppl 1):75-86. Resumen

73. Briceño-León R. Chagas disease in the Americas: an ecohealth perspective [in Spanish]. Cad Saude Publica. 2009;25(suppl 1):S71-82. Resumen

74. Gorla DE, Porcasi X, Hrellac H, et al. Spatial stratification of house infestation by Triatoma infestans in La Rioja, Argentina. Am J Trop Med Hyg. 2009 Mar;80(3):405-9. Resumen

75. Briceño-León R, Mendez Galván J. The social determinants of Chagas disease and the transformations of Latin America. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:109-12.Texto completo  Resumen

76. Araujo CA, Waniek PJ, Jansen AM. An overview of Chagas disease and the role of triatomines on its distribution in Brazil. Vector Borne Zoonotic Dis. 2009 Jun;9(3):227-34. Resumen

77. Hotez PJ. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis. 2008 Jun 25;2(6):e256.Texto completo  Resumen

78. Ventura-Garcia L, Roura M, Pell C, et al. Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2410.Texto completo  Resumen

79. Castro E. Chagas' disease: lessons from routine donation testing. Transfus Med. 2009 Feb;19(1):16-23.Texto completo  Resumen

80. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:75-85.Texto completo  Resumen

81. Agapova M, Busch MP, Custer B. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion. 2010 Oct;50(10):2220-32. Resumen

82. Diaz JH. Recognizing and reducing the risks of Chagas disease (American trypanosomiasis) in travelers. J Travel Med. 2008 May-Jun;15(3):184-95.Texto completo  Resumen

83. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, et al. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion. 2006 Feb;46(2):298-304. Resumen

84. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol. 1998 Nov;5(6):406-11. Resumen

85. Sabino EC, Salles NA, Sarr M, et al; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil. Transfusion. 2010 Dec;50(12):2628-37. Resumen

86. Altclas JD, Barcan L, Nagel C, et al. Organ transplantation and Chagas disease. JAMA. 2008 Mar 12;299(10):1134; author reply 1134-5. Resumen

87. Ferraz AS, Figueiredo JF. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):461-3. Resumen

88. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis. 2009 Jun 1;48(11):1534-40. Resumen

89. Barcán L, Lunaó C, Clara L, et al. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease. Liver Transpl. 2005 Sep;11(9):1112-6.Texto completo  Resumen

90. Souza FF, Castro-E-Silva O, Marin Neto JA, et al. Acute Chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc. 2008 Apr;40(3):875-8. Resumen

91. Kransdorf EP, Zakowski PC, Kobashigawa JA. Chagas disease in solid organ and heart transplantation. Curr Opin Infect Dis. 2014 Oct;27(5):418-24. Resumen

92. Wallace JA, Miller L, Beavis A, et al. Chagas disease: a proposal for testing policy for solid-organ transplant in the United States. Prog Transplant. 2013 Sep;23(3):272-7. Resumen

93. Villalba R, Fornes G, Alvarez MA, et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis. 1992 Feb;14(2):594-5. Resumen

94. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005 Jul;36(2):123-9.Texto completo  Resumen

95. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis. 1999 Jun;1(2):135-7. Resumen

96. Altclas J, Jaimovich G, Milovic V, et al. Chagas' disease after bone marrow transplantation. Bone Marrow Transplant. 1996 Aug;18(2):447-8. Resumen

97. Vazquez-Prokopec GM, Ceballos LA, Cecere MC, et al. Seasonal variations of microclimatic conditions in domestic and peridomestic habitats of Triatoma infestans in rural northwest Argentina. Acta Trop. 2002 Dec;84(3):229-38. Resumen

98. Medone P, Ceccarelli S, Parham PE, et al. The impact of climate change on the geographical distribution of two vectors of Chagas disease: implications for the force of infection. Philos Trans R Soc Lond B Biol Sci. 2015 Apr 5;370(1665). pii: 20130560. Resumen

99. Garza M, Feria Arroyo TP, Casillas EA, et al. Projected future distributions of vectors of Trypanosoma cruzi in North America under climate change scenarios. PLoS Negl Trop Dis. 2014 May 15;8(5):e2818.Texto completo  Resumen

100. Abad-Franch F, Monteiro FA. Biogeography and evolution of Amazonian triatomines (Heteroptera: Reduviidae): implications for Chagas disease surveillance in humid forest ecoregions. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:57-70.Texto completo  Resumen

101. Walsh JF, Molyneux DH, Birley MH. Deforestation: effects on vector-borne disease. Parasitology. 1993;106 Suppl:S55-75. Resumen

102. Hofflin JM, Sadler RH, Araujo FG, et al. Laboratory-acquired Chagas disease. Trans R Soc Trop Med Hyg. 1987;81(3):437-40. Resumen

103. Bern C, Montgomery SP. Recognizing and reducing the risks of Chagas disease in travelers. J Travel Med. 2008 Sep-Oct;15(5):385; author reply 386.Texto completo  Resumen

104. Jackson Y. International migration: global issue, local impact: the example of two parasites [in French]. Rev Med Suisse. 2009 May 6;5(202):1022-5. Resumen

105. Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, et al. Chagas disease travels to Europe. Lancet. 2009 Jun 13;373(9680):2025. Resumen

106. Manzardo C, Trevino B, Gomez i Prat J, et al. Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues. Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):4-11. Resumen

107. Takeno M, Seto S, Kawahara F, et al. Chronic Chagas' heart disease in a Japanese-Brazilian traveler: a case report. Jpn Heart J. 1999 May;40(3):375-82.Texto completo  Resumen

108. Blanco SB, Segura EL, Cura EN, et al. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health. 2000 Apr;5(4):293-301.Texto completo  Resumen

109. Bittencourt AL. Possible risk factors for vertical transmission of Chagas' disease. Rev Inst Med Trop Sao Paulo. 1992 Sep-Oct;34(5):403-8. Resumen

110. Brutus L, Schneider D, Postigo J, et al. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1159-60. Resumen

111. Gürtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis. 2003 Jan;9(1):29-32.Texto completo  Resumen

112. Olivera Mar A, Guillen Ortega F, Cruz Vidal S, et al. Serological and parasitological screening of Trypanosoma cruzi infection in mothers and newborns living in two Chagasic areas of Mexico. Arch Med Res. 2006 Aug;37(6):774-7. Resumen

113. Salas NA, Cot M, Schneider D, et al. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop Med Int Health. 2007 Dec;12(12):1498-505.Texto completo  Resumen

114. Di Pentima MC, Hwang LY, Skeeter CM, et al. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis. 1999 Jun;28(6):1281-5. Resumen

115. Dias JC. Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:41-5.Texto completo  Resumen

116. Guhl F, Pinto N, Aguilera G. Sylvatic triatominae: a new challenge in vector control transmission. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:71-5.Texto completo  Resumen

117. Noireau F. Wild Triatoma infestans, a potential threat that needs to be monitored. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:60-4.Texto completo  Resumen

118. Meymandi S, Hernandez S, Park S, et al. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018 Jun 26;10(3):373-88.Texto completo  Resumen

119. Milei J, Guerri-Guttenberg RA, Grana DR, et al. Prognostic impact of Chagas disease in the United States. Am Heart J. 2009 Jan;157(1):22-9. Resumen

120. Dias JP, Bastos C, Araujo E, et al. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop. 2008 May-Jun;41(3):296-300.Texto completo  Resumen

121. Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:167-80.Texto completo  Resumen

122. Gomes YM, Lorena VM, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:115-21.Texto completo  Resumen

123. Dubner S, Schapachnik E, Riera AR, et al. Chagas disease: state-of-the-art of diagnosis and management. Cardiol J. 2008;15(6):493-504. Resumen

124. Brasil PE, De Castro L, Hasslocher-Moreno AM, et al. ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect Dis. 2010 Nov 25;10:337.Texto completo  Resumen

125. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007 Mar 6;115(9):1101-8.Texto completo  Resumen

126. Benchimol Barbosa PR. Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2007 Feb;40(2):167-78.Texto completo  Resumen

127. Bestetti RB, Dalbo CM, Arruda CA, et al. Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study. Cardiology. 1996 Nov-Dec;87(6):481-7. Resumen

128. Meneghelli UG, Peria FM, Darezzo FM, et al. Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas' disease. Dysphagia. 2005 Winter;20(1):40-5. Resumen

129. Meneghelli UG. Chagasic enteropathy. Rev Soc Bras Med Trop. 2004 May-Jun;37(3):252-60. Resumen

130. Benchimol-Barbosa PR. Predictors of mortality in Chagas' disease: the impact of atrial fibrillation and oral transmission on infected population. Int J Cardiol. 2009 Apr 3;133(2):275-7. Resumen

131. Dantas RO. Comparison between idiopathic achalasia and achalasia caused by Chagas' disease: a review on the publications about the subject [in Portuguese]. Arq Gastroenterol. 2003 Apr-Jun;40(2):126-30. Resumen

132. Dantas RO. Effect of successive swallows on oesophageal motility of normal volunteers, patients with Chagas' disease and patients with idiopathic achalasia. Neurogastroenterol Motil. 2003 Feb;15(1):57-62. Resumen

133. Dantas RO. Vigorous achalasia in Chagas' disease. Dis Esophagus. 2002;15(4):305-8. Resumen

134. Dantas RO. Upper esophageal sphincter pressure in patients with Chagas' disease and primary achalasia. Braz J Med Biol Res. 2000 May;33(5):545-51.Texto completo  Resumen

135. Dantas RO. Dysphagia in patients with Chagas' disease. Dysphagia. 1998 Winter;13(1):53-7. Resumen

136. Otani MM, Vinelli E, Kirchhoff LV, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009 Jun;49(6):1076-82. Resumen

137. Caballero ZC, Sousa OE, Marques WP, et al. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol. 2007 Aug;14(8):1045-9.Texto completo  Resumen

138. Xavier SS, Sousa AS, Hasslocher-Moreno A. Application of the new classification of cardiac insufficiency (ACC/AHA) in chronic Chagas cardiopathy: a critical analysis of the survival curves. SOCERJ. 2005;18:227-32.Texto completo

139. Carrasco HA, Barboza JS, Inglessis G, et al. Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage. Am Heart J. 1982 Sep;104(3):595-602. Resumen

140. Kuschnir E, Sgammini H, Castro R, et al. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy [in Spanish]. Arq Bras Cardiol. 1985 Oct;45(4):249-56. Resumen

141. Bern C, Montgomery SP, Katz L, et al. Chagas disease and the US blood supply. Curr Opin Infect Dis. 2008 Oct;21(5):476-82. Resumen

142. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant. 2011 Apr;11(4):672-80.Texto completo  Resumen

143. Gross PA, Barrett TL, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis. 1994 Mar;18(3):421. Resumen

144. Coura JR. Present situation and new strategies for Chagas disease chemotherapy - a proposal. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):549-54.Texto completo  Resumen

145. Fernandes CD, Tiecher FM, Balbinot MM, et al. Efficacy of benznidazole treatment for asymptomatic Chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. Mem Inst Oswaldo Cruz. 2009 Feb;104(1):27-32.Texto completo  Resumen

146. Dias JC, Coura JR, Yasuda MA. The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease. Rev Soc Bras Med Trop. 2014 Jan-Feb;47(1):123-5.Texto completo  Resumen

147. Norman FF, López-Vélez R. Chagas disease and breast-feeding. Emerg Infect Dis. 2013 Oct;19(10):1561-6.Texto completo  Resumen

148. Abbott A, Montgomery SP, Chancey RJ. Characteristics and adverse events of patients for whom nifurtimox was released through CDC-sponsored investigational new drug program for treatment of Chagas disease - United States, 2001-2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):371-4.Texto completo  Resumen

149. World Health Organization. Chagas disease (American trypanosomiasis): treatment. 2018 [internet publication].Texto completo

150. Bestetti RB, Theodoropoulos TA. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail. 2009 Apr;15(3):249-55. Resumen

151. Urbina JA. Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives. J Eukaryot Microbiol. 2015 Jan-Feb;62(1):149-56. Resumen

152. Campi-Azevedo AC, Gomes JA, Teixeira-Carvalho A, et al. Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events. Immunobiology. 2015 May;220(5):564-74. Resumen

153. Barbosa JL, Thiers CA, de Bragança Pereira B, et al. Impact of the use of benznidazole followed by antioxidant supplementation in the prevalence of ventricular arrhythmias in patients with chronic Chagas disease: pilot study. Am J Ther. 2016 Nov/Dec;23(6):e1474-83. Resumen

154. Fabbro DL, Danesi E, Olivera V, et al. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312.Texto completo  Resumen

155. Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic chagas' cardiomyopathy. N Engl J Med. 2015 Oct;373(14):1295-306.Texto completo  Resumen

156. Vallejo M, Reyes PPA, Garcia MM, et al. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD004102.Texto completo  Resumen

157. Bittencourt HS, Rodrigues Junior Ede S, Cruz CG, et al. Neuromuscular electrical stimulation in a patient with chronic heart failure due to Chagas disease: a case report. Clinics (Sao Paulo). 2011;66(5):927-8.Texto completo  Resumen

158. Mendes MFA, Lopes WS, Nogueira GA, et al. Aerobic physical exercise in women with Chagas disease [in Portuguese]. Fisioter Mov. 2011;24(4):591-601.Texto completo

159. Lima MM, Rocha MO, Nunes MC, et al. A randomized trial of the effects of exercise training in Chagas cardiomyopathy. Eur J Heart Fail. 2010 Aug;12(8):866-73.Texto completo  Resumen

160. Fialho PH, Tura BR, Sousa AS, et al. Effects of an exercise program on the functional capacity of patients with chronic Chagas' heart disease, evaluated by cardiopulmonary testing. Rev Soc Bras Med Trop. 2012 Mar-Apr;45(2):220-4. Resumen

161. Mediano MF, Mendes Fde S, Pinto VL, et al. Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study. Rev Soc Bras Med Trop. 2016 May-Jun;49(3):319-28.Texto completo  Resumen

162. Martí-Carvajal AJ, Kwong JS. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy. Cochrane Database Syst Rev. 2016 Jul 8;(7):CD009077.Texto completo  Resumen

163. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39.Texto completo  Resumen

164. Aulet F, Riarte A, Pattin M, et al. Chagas disease and kidney transplantation. Transplant Proc. 1991 Oct;23(5):2653. Resumen

165. de Arteaga J, Massari PU, Galli B, et al. Renal transplantation and Chagas' disease. Transplant Proc. 1992 Oct;24(5):1900-1. Resumen

166. de Faria JB, Alves G. Transmission of Chagas' disease through cadaveric renal transplantation. Transplantation. 1993 Dec;56(6):1583-4. Resumen

167. Vazquez MC, Riarte A, Pattin M, et al. Chagas' disease can be transmitted through kidney transplantation. Transplant Proc. 1993 Dec;25(6):3259-60. Resumen

168. Vazquez MC, Sabbatiello R, Schiavelli R, et al. Chagas disease and transplantation. Transplant Proc. 1996 Dec;28(6):3301-3. Resumen

169. Rassi A Jr, Dias JC, Marin-Neto JA, et al. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart. 2009 Apr;95(7):524-34. Resumen

170. Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999 Sep;29(3):561-7. Resumen

171. Keenan M, Chaplin JH. A new era for Chagas disease drug discovery? Prog Med Chem. 2015;54:185-230. Resumen

172. Morilla MJ, Romero EL. Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis. Nanomedicine (Lond). 2015 Feb;10(3):465-81. Resumen

173. NIH US National Library of Medicine: ClinicalTrials.gov. Oral fexinidazole dosing regimens for the treatment of adults with chronic indeterminate Chagas disease (FEXI12). July 2018 [internet publication].Texto completo

174. Borges Migliavaca C, Stein C, Colpani V, et al. Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Sep;12(9):e0006836.Texto completo  Resumen

175. Stein C, Migliavaca CB, Colpani V, et al. Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis. PLoS Negl Trop Dis. 2018 Aug;12(8):e0006742.Texto completo  Resumen

176. NIH US National Library of Medicine: ClinicalTrials.gov. A trial testing amiodarone in Chagas cardiomiopathy (ATTACH). June 2017 [internet publication].Texto completo

177. Campos de Carvalho AC, Goldenberg RC, Jelicks LA, et al. Cell therapy in Chagas disease. Interdiscip Perspect Infect Dis. 2009;2009:484358.Texto completo  Resumen

178. Soares MB, dos Santos RR. Current status and perspectives of cell therapy in Chagas disease. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:325-32.Texto completo  Resumen

179. Zhang Y, Mi JY, Rui YJ, et al. Stem cell therapy for the treatment of parasitic infections: is it far away? Parasitol Res. 2014 Feb;113(2):607-12. Resumen

180. de Carvalho KA, Abdelwahid E, Ferreira RJ, et al. Preclinical stem cell therapy in Chagas Disease: perspectives for future research. World J Transplant. 2013 Dec 24;3(4):119-26.Texto completo  Resumen

181. Silva DN, de Freitas Souza BS, Azevedo CM, et al. Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy. Stem Cell Res Ther. 2014 Jul 1;5(4):81.Texto completo  Resumen

182. Soares MB, Lima RS, Rocha LL, et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic Chagasic mice. Am J Pathol. 2004 Feb;164(2):441-7. Resumen

183. Goldenberg RC, Jelicks LA, Fortes FS, et al. Bone marrow cell therapy ameliorates and reverses Chagasic cardiomyopathy in a mouse model. J Infect Dis. 2008 Feb 15;197(4):544-7. Resumen

184. Vilas-Boas F, Feitosa GS, Soares MB, et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease [in Portuguese]. Arq Bras Cardiol. 2006 Aug;87(2):159-66. Resumen

185. Ribeiro Dos Santos R, Rassi S, Feitosa G, et al; Chagas Arm of the MiHeart Study Investigators. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation. 2012 May 22;125(20):2454-61.Texto completo  Resumen

186. Camargo EP. Perspectives of vaccination in Chagas disease revisited. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:275-80.Texto completo  Resumen

187. Cazorla SI, Frank FM, Malchiodi EL. Vaccination approaches against Trypanosoma cruzi infection. Expert Rev Vaccines. 2009 Jul;8(7):921-35. Resumen

188. Duschak VG, Couto AS. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-202. Resumen

189. Schnapp AR, Eickhoff CS, Sizemore D, et al. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun. 2002 Sep;70(9):5065-74.Texto completo  Resumen

190. Bontempi IA, Vicco MH, Cabrera G, et al. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Vaccine. 2015 Mar 3;33(10):1274-83. Resumen

191. Serna C, Lara JA, Rodrigues SP, et al. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. Vaccine. 2014 Jun 12;32(28):3525-32.Texto completo  Resumen

192. Tekiel V, Alba-Soto CD, Gonzalez Cappa SM, et al. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Resumen

193. Gupta S, Wan X, Zago MP, et al. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease. PLoS Negl Trop Dis. 2013;7(1):e2018.Texto completo  Resumen

194. Basso B. Modulation of immune response in experimental Chagas disease. World J Exp Med. 2013 Feb 20;3(1):1-10.Texto completo  Resumen

195. Balouz V, Cámara Mde L, Cánepa GE, et al. Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi. Clin Vaccine Immunol. 2015 Mar;22(3):304-12. Resumen

196. Jannin J, Salvatella R, eds. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: OPS/HDM/CD/425-06; 2006:28.

197. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2197-223. Resumen

198. Lee BY, Bacon KM, Bottazzi ME, et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013 Apr;13(4):342-8.Texto completo  Resumen

199. World Health Organization. World Health Report 2004: changing history. Geneva: WHO; 2004:120-1,126-7.Texto completo

200. Martins-Melo FR, Alencar CH, Ramos AN Jr, et al. Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007. PLoS Negl Trop Dis. 2012;6(2):e1508.Texto completo  Resumen

201. Sartori AM, Caiaffa-Filho HH, Bezerra RC, et al. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg. 2002 Nov;67(5):521-3.Texto completo  Resumen

202. Sartori AM, Shikanai-Yasuda MA, Amato Neto V, et al. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis. 1998 Jan;26(1):177-9. Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad